Current knowledge and challenges of antimalarial drugs for treatment and prevention in pregnancy

Bibliography

• WHO. World malaria report 2008. World Health Organization; 2008. WHO/HTM/GMP/2008.1
   Google Scholar
• Singh B, Kim Sung L, Matuso PA, A large focus of naturally acquired Plasmodium knowlesi infections in human beings. Lancet 2004;363:1017-24
   PubMed Web of Science ®Google Scholar
• WHO. A strategic framework for malaria prevention and control during pregnancy in the African region. World Health Organization, Geneva 2004, 2004: AFR/MAL
   Google Scholar
• Lindsay S, Ansell J, Selman C, Effect of pregnancy on exposure to malaria mosquitoes. Lancet 2000;355:1972
   PubMed Web of Science ®Google Scholar
• Ansell J, Hamilton KA, Pinder M, Short-range attractiveness of pregnant women to Anopheles gambiae mosquitoes. Trans R Soc Trop Med Hyg 2002;96:113-116
   PubMed Web of Science ®Google Scholar
• Desai M, ter Kuile FO, Nosten F, Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis 2007;7:93-104
   PubMed Web of Science ®Google Scholar
• Menendez C, D'Alessandro U, ter Kuile FO. Reducing the burden of malaria in pregnancy by preventive strategies. Lancet Infect Dis 2007;7:126-35
   PubMed Web of Science ®Google Scholar
• Schwarz NG, Adegnika AA, Breitling LP, Placental malaria increases malaria risk in the first 30 months of life. Clin Infect Dis 2008;47:1017-25
   PubMed Web of Science ®Google Scholar
• van Geertruyden JP, Thomas F, Erhart A, D'Alessandro U. The contribution of malaria in pregnancy to perinatal mortality. Am J Trop Med Hyg 2004;71:35-40
   PubMed Web of Science ®Google Scholar
• Steketee RW, Nahlen BL, Parise ME, The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg 2001;64:28-35
   PubMed Web of Science ®Google Scholar
• Le Hesran JY, Fievet N, Thioulouse J, Development of cellular immune responses to Plasmodium falciparum blood stage antigens from birth to 36 months of age in Cameroon. Acta Trop 2006;98:261-9
   Google Scholar
• Brabin BJ. An analysis of malaria in pregnancy in Africa. Bull World Health Organ 1983;61:1005-16
   PubMed Web of Science ®Google Scholar
• Shulman CE Dorman EK, Bulmer JN. Malaria as a cause of severe anaemia in pregnancy. Lancet 2002;360:494
   Google Scholar
• Greenwood BM, Greenwood AM, Snow RW, The effects of malaria chemoprophylaxis given by traditional birth attendantes on the course and outcome of pregnancy. Trans R Soc Trop Med Hyg 1989;83:589-94
   PubMed Web of Science ®Google Scholar
• Menendez C, Ordi J, Ismail MR, The impact of placental malaria on gestational age and birth weight. J Infect Dis 2000;181:1740-5
   PubMed Web of Science ®Google Scholar
• Granja AC, Machungo F, Gomes A, Malaria-related maternal mortality in urban Mozambique. Ann Trop Med Parasitol 1998;92:257-63
   PubMed Web of Science ®Google Scholar
• Menendez C, Bardaji A, Sigauque B, A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic. PLoS One 2008;3:e1934
   PubMed Web of Science ®Google Scholar
• Greenwood D. The quinine connection. J Antimicrob Chemother 1992;30:417-27
   PubMed Web of Science ®Google Scholar
• Payne D. Did medicated salt hasten the spread of chloroquine resistance in Plasmodium falciparum? Parasitol Today 1988;4:112-5
   PubMedGoogle Scholar
• Myint HY, Ashley EA, Day NP, Efficacy and safety of dihydroartemisinin-piperaquine. Trans R Soc Trop Med Hyg 2007;101:858-66
   PubMed Web of Science ®Google Scholar
• Trouiller P, Olliaro P, Torreele E, Drug development for neglected diseases: a deficient market and a public-health policy failure. Lancet 2002;359:2188-94
   PubMed Web of Science ®Google Scholar
• WHO. WHO guidelines for the treatment of malaria; 2006. WHO/HTM/MAL/2006.1108
   Google Scholar
• Nosten F, Rogerson SJ, Beeson JG, Malaria in pregnancy and the endemicity spectrum: what can we learn? Trends Parasitol 2004;20:425-32
   PubMed Web of Science ®Google Scholar
• Guyatt HL, Snow RW. The epidemiology and burden of Plasmodium falciparum-related anemia among pregnant women in sub-Saharan Africa. Am J Trop Med Hyg 2001;64:36-44
   PubMed Web of Science ®Google Scholar
• Bardaji A, Sigauque B, Bruni L, Clinical malaria in African pregnant women. Malar J 2008;7:27
   PubMed Web of Science ®Google Scholar
• Maitra N, Joshi M, Hazra M. Maternal manifestations of malaria in pregnancy: a review. Indian J Matern Child Health 1993;4:98-101
   PubMedGoogle Scholar
• Kalia S, Dutz JP. New concepts in antimalarial use and mode of action in dermatology. Dermatol Ther 2007;20:160-74
   PubMed Web of Science ®Google Scholar
• Khatoon L, Baliraine FN, Bonizzoni M, Prevalence of antimalarial drug resistance mutations in Plasmodium vivax and P. falciparum from a malaria-endemic area of Pakistan. Am J Trop Med Hyg 2009;81:525-8
   PubMed Web of Science ®Google Scholar
• Lee SW, Lee M, Lee DD, Biological resistance of hydroxychloroquine for Plasmodium vivax malaria in the Republic of Korea. Am J Trop Med Hyg 2009;81:600-604
   Google Scholar
• Laufer MK, Thesing PC, Eddington ND, Return of chloroquine antimalarial efficacy in Malawi. N Engl J Med 2006;355:1959-66
   PubMed Web of Science ®Google Scholar
• Alkadi HO. Antimalarial drug toxicity: a review. Chemotherapy 2007;53:385-91
   PubMed Web of Science ®Google Scholar
• Phillips-Howard PA Wood D. The safety of anti-malarial drugs in pregnancy. Drug Saf 1996;14:131-45
   PubMed Web of Science ®Google Scholar
• Steketee RW, Wirima JJ, Slutsker L, Malaria treatment and prevention in pregnancy: indications for use and adverse events associated with use of chloroquine or mefloquine. Am J Trop Med Hyg 1996;55:50-6
   PubMed Web of Science ®Google Scholar
• Motta M, Tincani A, Faden D, Antimalarial agents in pregnancy. Lancet 2002;359:524-5
   PubMed Web of Science ®Google Scholar
• Akintonwa A, Gbajumo SA, Mabadeje AF. Placental and milk transfer of chloroquine in humans. Ther Drug Monit 1988;10:147-9
   PubMed Web of Science ®Google Scholar
• Chukwuani MC, Bolaji OO, Onyeji CO, Evidence for increased metabolism of chloroquine during the early third trimester of human pregnancy. Trop Med Int Health 2004;9:601-5
   PubMed Web of Science ®Google Scholar
• Lee SJ, McGready R, Fernandez C, Chloroquine pharmacokinetics in pregnant and nonpregnant women with vivax malaria. Eur J Clin Pharmacol 2008;64:987-92
   PubMed Web of Science ®Google Scholar
• Dipiro JT, Talbert RL, Yee GC, Pharmacotherapy: a pathophysiologic approach. Appleton & Lange, Stanford-Connecticut, USA; 1997
   Google Scholar
• Hatton CS, Peto TE, Bunch C, Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Lancet 1986;1:411-14
   PubMed Web of Science ®Google Scholar
• Taylor WR, White NJ. Antimalarial drug toxicity: a review. Drug Saf 2004;27:25-61
   PubMed Web of Science ®Google Scholar
• Thomas F, Erhart A, D'Alessandro U. Can amodiaquine be used safely during pregnancy? Lancet Infect Dis 2004;4:235-9
   PubMed Web of Science ®Google Scholar
• White NJ. Clinical pharmacokinetics of antimalarial drugs. Clin Pharmacokinet 1985;10:187-215
   PubMed Web of Science ®Google Scholar
• Ward SA, Sevene EJ, Hastings IM, Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance. Lancet Infect Dis 2007;7:136-44
   PubMed Web of Science ®Google Scholar
• Tagbor HK, Chandramohan D, Greenwood B. The safety of amodiaquine use in pregnant women. Expert Opin Drug Saf 2007;6:631-5
   PubMed Web of Science ®Google Scholar
• Ashley EA, Krudsood S, Phaiphun L, Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand. J Infect Dis 2004;190:1773-82
   PubMed Web of Science ®Google Scholar
• Schlitzer M. Antimalarial drugs – what is in use and what is in the pipeline. Arch Pharm (Weinheim) 2008;341:149-63
   PubMed Web of Science ®Google Scholar
• Adam I, Idris HM, Elbashir MI. Quinine for chloroquine-resistant falciparum malaria in pregnant Sudanese women in the first trimester. East Mediterr Health J 2004;10:560-5
   PubMedGoogle Scholar
• McGready R, Brockman A, Cho T, Randomized comparison of mefloquine-artesunate versus quinine in the treatment of multidrug-resistant falciparum malaria in pregnancy. Trans R Soc Trop Med Hyg 2000;94:689-93
   PubMed Web of Science ®Google Scholar
• Bounyasong S. Randomized trial of artesunate and mefloquine in comparison with quinine sulfate to treat P. falciparum malaria pregnant women. J Med Assoc Thai 2001;84:1289-99
   PubMedGoogle Scholar
• Bateman DN, Dyson EH. Quinine toxicity. Adverse Drug React Acute Poisoning Rev 1986;5:215-33
   PubMedGoogle Scholar
• Kochar DK, Kumawat BL, Kochar SK, Sanwal V. Hypoglycemia after oral quinine administration. J Assoc Physicians India 1995;43:654, 657
   Google Scholar
• Rogerson SJ, Menendez C. Treatment and prevention of malaria in pregnancy: opportunities and challenges. Expert Rev Anti Infect Ther 2006;4:687-702
   PubMedGoogle Scholar
• White NJ, Looareesuwan S, Warrell DA, Quinine pharmacokinetics and toxicity in cerebral and uncomplicated falciparum malaria. Am J Med 1982;73:564-72
   PubMed Web of Science ®Google Scholar
• Nosten F, McGready R, d'Alessandro U, Antimalarial drugs in pregnancy: a review. Curr Drug Saf 2006;1:1-15
   PubMedGoogle Scholar
• Babalola CP, Bolaji OO, Ogunbona FA, Pharmacokinetics of quinine in African patients with acute falciparum malaria. Pharm World Sci 1998;20:118-22
   Google Scholar
• Sowunmi A. Disposition of oral quinine in African patients suffering from acute uncomplicated falciparum malaria. East Afr Med J 1996;73:519-23
   Google Scholar
• Supanaranond W, Davis TM, Pukrittayakamee S, Disposition of oral quinine in acute falciparum malaria. Eur J Clin Pharmacol 1991;40:49-52
   Google Scholar
• Phillips RE, Looareesuwan S, White NJ, Quinine pharmacokinetics and toxicity in pregnant and lactating women with falciparum malaria. Br J Clin Pharmacol 1986;21:677-83
   PubMed Web of Science ®Google Scholar
• Abdelrahim, II, Adam I, Elghazali G, Pharmacokinetics of quinine and its metabolites in pregnant Sudanese women with uncomplicated Plasmodium falciparum malaria. J Clin Pharm Ther 2007;32:15-19
   PubMed Web of Science ®Google Scholar
• Carrara VI, Zwang J, Ashley EA, Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment. PLoS One 2009;4:e4551
   PubMed Web of Science ®Google Scholar
• Nosten F, van Vugt M, Price R, Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet 2000;356:297-302
   PubMed Web of Science ®Google Scholar
• Orton LC, Omari AA. Drugs for treating uncomplicated malaria in pregnant women. Cochrane Database Syst Rev 2008;(4):CD004912
   Google Scholar
• Adam I, Ali DA, Alwaseila A, Mefloquine in the treatment of falciparum malaria during pregnancy in Eastern Sudan. Saudi Med J 2004;25:1400-2
   PubMed Web of Science ®Google Scholar
• Weinke T, Trautmann M, Held T, Neuropsychiatric side effects after the use of mefloquine. Am J Trop Med Hyg 1991;45:86-91
   PubMed Web of Science ®Google Scholar
• Udry E, Bailly F, Dusmet M, Pulmonary toxicity with mefloquine. Eur Respir J 2001;18:890-2
   Google Scholar
• Katsenos S, Psathakis K, Nikolopoulou MI, Mefloquine-induced eosinophilic pneumonia. Pharmacotherapy 2007;27:1767-71
   Google Scholar
• Inoue T, Tanaka E, Sakuramoto M, Case of drug-induced pneumonia possibly due to mefloquine (antimalarial drug). Nihon Kokyuki Gakkai Zasshi 2005;43:103-7
   Google Scholar
• White NJ. Cardiotoxicity of antimalarial drugs. Lancet Infect Dis 2007;7:549-58
   PubMed Web of Science ®Google Scholar
• Fonteyne W, Bauwens A, Jordaens L. Atrial flutter with 1:1 conduction after administration of the antimalarial drug mefloquine. Clin Cardiol 1996;19:967-8
   PubMed Web of Science ®Google Scholar
• Vanhauwere B, Maradit H, Kerr L. Post-marketing surveillance of prophylactic mefloquine (Lariam) use in pregnancy. Am J Trop Med Hyg 1998;58:17-21
   PubMed Web of Science ®Google Scholar
• Newman RD, Parise ME, Slutsker L, Safety, efficacy and determinants of effectiveness of antimalarial drugs during pregnancy: implications for prevention programmes in Plasmodium falciparum-endemic sub-Saharan Africa. Trop Med Int Health 2003;8:488-506
   PubMed Web of Science ®Google Scholar
• Nosten F, Vincenti M, Simpson J, The effects of mefloquine treatment in pregnancy. Clin Infect Dis 1999;28:808-15
   PubMed Web of Science ®Google Scholar
• Phillips-Howard PA, Steffen R, Kerr L, Safety of mefloquine and other antimalarial agents in the first trimester of pregnancy. J Travel Med 1998;5:121-6
   PubMed Web of Science ®Google Scholar
• Omari AA, Preston C, Garner P. Artemether-lumefantrine for treating uncomplicated falciparum malaria. Cochrane Database Syst Rev 2003;3:CD003125
   Google Scholar
• van Vugt M, Ezzet F, Nosten F, No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine. Am J Trop Med Hyg 1999;61:964-7
   PubMed Web of Science ®Google Scholar
• Falade C, Manyando C. Safety profile of Coartem: the evidence base. Malar J 2009;8(Suppl 1):S6
   Google Scholar
• Tarning J, McGready R, Lindegardh N, Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria. Antimicrob Agents Chemother 2009;53:3837-46
   PubMed Web of Science ®Google Scholar
• McGready R, Tan SO, Ashley EA, A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated Plasmodium falciparum treatment in pregnancy. PLoS Med 2008;5:e253
   PubMed Web of Science ®Google Scholar
• McGready R, Stepniewska K, Lindegardh N, The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria. Eur J Clin Pharmacol 2006;62:1021-31
   PubMed Web of Science ®Google Scholar
• Chavalitshewinkoon-Petmitr P, Pongvilairat G, Auparakkitanon S, Gametocytocidal activity of pyronaridine and DNA topoisomerase II inhibitors against multidrug-resistant Plasmodium falciparum in vitro. Parasitol Int 2000;48:275-80
   Google Scholar
• Ramharter M, Kurth F, Schreier AC, Fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon. J Infect Dis 2008;198:911-919
   PubMed Web of Science ®Google Scholar
• Steffen R, Somaini B. Severe cutaneous adverse reactions to sulfadoxine-pyrimethamine in Switzerland. Lancet 1986;1:610
   PubMed Web of Science ®Google Scholar
• Alloueche A, Bailey W, Barton S, Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial. Lancet 2004;363:1843-8
   PubMed Web of Science ®Google Scholar
• White NJ. The treatment of malaria. N Engl J Med 1996;335:800-6
   PubMed Web of Science ®Google Scholar
• Parise ME, Ayisi JG, Nahlen BL, Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg 1998;59:813-22
   PubMed Web of Science ®Google Scholar
• Karbwang J, Harinasuta T. Overview: clinical pharmacology of antimalarials. Southeast Asian J Trop Med Public Health 1992;23(Suppl 4):95-109
   Google Scholar
• Nyunt MM, Adam I, Kayentao K, Pharmacokinetics of sulfadoxine and pyrimethamine in intermittent preventive treatment of malaria in pregnancy. Clin Pharmacol Ther 2010;87(2):226-34
   Google Scholar
• Green MD, van Eijk AM, van Ter Kuile FO, Pharmacokinetics of sulfadoxine-pyrimethamine in HIV-infected and uninfected pregnant women in Western Kenya. J Infect Dis 2007;196:1403-8
   PubMed Web of Science ®Google Scholar
• Schlagenhauf P, Petersen E. Malaria chemoprophylaxis: strategies for risk groups. Clin Microbiol Rev 2008;21:466-72
   PubMed Web of Science ®Google Scholar
• Wangboonskul J, White NJ, Nosten F, Single dose pharmacokinetics of proguanil and its metabolites in pregnancy. Eur J Clin Pharmacol 1993;44:247-51
   PubMed Web of Science ®Google Scholar
• Meshnick SR. Artemisinin: mechanisms of action, resistance and toxicity. Int J Parasitol 2002;32:1655-60
   PubMed Web of Science ®Google Scholar
• White TE, Bushdid PB, Ritter S, Artesunate-induced depletion of embryonic erythroblasts precedes embryolethality and teratogenicity in vivo. Birth Defects Res B Dev Reprod Toxicol 2006;77:413-29
   PubMed Web of Science ®Google Scholar
• Clark RL KM, Makori N, Nakata Y, Artesunate: embryolethal effects in cynomolgus monkeys. Am J Trop Med Hyg 2006;75:54
   Google Scholar
• McGready R, Stepniewska K, Ward SA, Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria. Eur J Clin Pharmacol 2006;62:367-71
   PubMed Web of Science ®Google Scholar
• Goodman CD, Su V, McFadden GI. The effects of anti-bacterials on the malaria parasite Plasmodium falciparum. Mol Biochem Parasitol 2007;152:181-91
   PubMed Web of Science ®Google Scholar
• Lell B, Kremsner PG. Clindamycin as an antimalarial drug: review of clinical trials. Antimicrob Agents Chemother 2002;46:2315-20
   PubMed Web of Science ®Google Scholar
• McGready R, Cho T, Samuel, Randomized comparison of quinine-clindamycin versus artesunate in the treatment of falciparum malaria in pregnancy. Trans R Soc Trop Med Hyg 2001;95:651-6
   PubMed Web of Science ®Google Scholar
• Noedl H, Krudsood S, Chalermratana K, Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand. Clin Infect Dis 2006;43:1264-71
   PubMed Web of Science ®Google Scholar
• Miller RS, Wongsrichanalai C, Buathong N, Effective treatment of uncomplicated Plasmodium falciparum malaria with azithromycin-quinine combinations: a randomized, dose-ranging study. Am J Trop Med Hyg 2006;74:401-6
   PubMed Web of Science ®Google Scholar
• Kalilani L MI, Chaponda M, Rogerson SJ, A randomized controlled pilot trial of azithromycin or artesunate added to sulfadoxine-pyrimethamine as treatment for malaria in pregnant women. PLoS One 2007;2:e1166
   Google Scholar
• Chico RM, Pittrof R, Greenwood B, Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy. Malar J 2008;7:255
   PubMed Web of Science ®Google Scholar
• Van Vranken M. Prevention and treatment of sexually transmitted diseases: an update. Am Fam Physician 2007;76:1827-32
   PubMed Web of Science ®Google Scholar
• Kremsner PG, Krishna S. Antimalarial combinations. Lancet 2004;364:285-94
   PubMed Web of Science ®Google Scholar
• WHO. Antimalarial drug combination therapy: report of a WHO Technical Consultation. World Health Organization, Geneva; 2001. WHO/CDS/RBM/2001.35
   Google Scholar
• Mutabingwa TK, Muze K, Ord R, Randomized trial of artesunate+amodiaquine, sulfadoxine-pyrimethamine+amodiaquine, chlorproguanal-dapsone and SP. for malaria in pregnancy in Tanzania. PLoS One 2009;4:e5138
   PubMed Web of Science ®Google Scholar
• Fanello CI, Karema C, Avellino P, High risk of severe anaemia after chlorproguanil-dapsone+artesunate antimalarial treatment in patients with G6PD (A-) deficiency. PLoS One 2008;3:e4031
   Google Scholar
• Miller AK, Bandyopadhyay N, Wootton DG, Pharmacokinetics of chlorproguanil, dapsone, artesunate and their major metabolites in patients during treatment of acute uncomplicated Plasmodium falciparum malaria. Eur J Clin Pharmacol 2009;65:977-87
   PubMed Web of Science ®Google Scholar
• Osei-Akoto A, Orton L, Owusu-Ofori SP. Atovaquone-proguanil for treating uncomplicated malaria. Cochrane Database Syst Rev 2005;(4):CD004529
   Google Scholar
• McGready R AE, Moo E, Cho T, A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy. J Infect Dis 2005;192:846-53
   Google Scholar
• McIntosh HM GB. Chloroquine or amodiaquine combined with sulphadoxine-pyrimethamine as a treatment for uncomplicated malaria: a systematic review. Ann Trop Med Parasitol 1998;92:265-70
   Google Scholar
• Deen JL, von Seidlein L, Pinder M, The safety of the combination artesunate and pyrimethamine-sulfadoxine given during pregnancy. Trans R Soc Trop Med Hyg 2001;95:424-8
   PubMed Web of Science ®Google Scholar
• Tran TH, Dolecek C, Pham PM, Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial. Lancet 2004;363:18-22
   PubMed Web of Science ®Google Scholar
• Thanh NX, Trung TN, Phong NC, Open label randomized comparison of dihydroartemisinin-piperaquine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in central Vietnam. Trop Med Int Health 2009;14:504-11
   Google Scholar
• Rijken MJ, McGready R, Boel ME, Dihydroartemisinin-piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report. Am J Trop Med Hyg 2008;78:543-5
   PubMed Web of Science ®Google Scholar
• Sagara I, Diallo A, Kone M, A randomized trial of artesunate-mefloquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali. Am J Trop Med Hyg 2008;79:655-61
   PubMedGoogle Scholar
• Nagelschmitz J, Voith B, Wensing G, First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisone. Antimicrob Agents Chemother 2008;52:3085-91
   PubMed Web of Science ®Google Scholar
• Casagrande M, Basilico N, Parapini S, Novel amodiaquine congeners as potent antimalarial agents. Bioorg Med Chem 2008;16:6813-23
   PubMed Web of Science ®Google Scholar
• Solomon VR, Haq W, Smilkstein M, Synthesis and antimalarial activity of novel side chain modified antimalarial agents derived from 4-aminoquinoline. Med Chem 2008;4:446-56
   PubMedGoogle Scholar
• Stocks PA, Raynes KJ, Bray PG, Novel short chain chloroquine analogues retain activity against chloroquine resistant K1 Plasmodium falciparum. J Med Chem 2002;45:4975-83
   PubMed Web of Science ®Google Scholar
• Ruangweerayut R, Looareesuwan S, Hutchinson D, Assessment of the pharmacokinetics and dynamics of two combination regimens of fosmidomycin-clindamycin in patients with acute uncomplicated falciparum malaria. Malar J 2008;7:225
   PubMed Web of Science ®Google Scholar
• CDC. Centers for Disease Control Recommendations for the prevention of malaria among travellers. MMWR 1990;39:1-10
   PubMedGoogle Scholar
• Greenwood B. The use of antimalarial drugs to prevent malaria in the population of malaria endemic areas. Am J Trop Med Hyg 2004;70:1-7
   PubMed Web of Science ®Google Scholar
• Garner P, Gülmezoglu AM. Prevention versus treatment for malaria in pregnant women. Cochrane Database Syst Rev 2000;(2):CD000169
   Google Scholar
• Brentlinger PE, Dgedge M, Correia MA, Intermittent preventive treatment of malaria during pregnancy in central Mozambique. Bull World Health Organ 2007;85:873-9
   PubMed Web of Science ®Google Scholar
• Mockenhaupt FP, Bedu-Addo G, Eggelte TA, Rapid increase in the prevalence of sulfadoxine-pyrimethamine resistance among Plasmodium falciparum isolated from pregnant women in Ghana. J Infect Dis 2008;198:1545-9
   PubMed Web of Science ®Google Scholar
• Harrington WE, Mutabingwa TK, Muehlenbachs A, Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment. Proc Natl Acad Sci USA 2009;106:9027-32
   PubMed Web of Science ®Google Scholar
• Clerk CA, Bruce J, Affipunguh PK, A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana. J Infect Dis 2008;198:1202-11
   PubMed Web of Science ®Google Scholar
• Briand V, Bottero J, Noel H, Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine. J Infect Dis 2009;200:991-1001
   PubMed Web of Science ®Google Scholar
• WHO. Assessment of the safety of artemisinin compounds in pregnancy. Report of two joint informal consultations convened in 2006 by TDR and the Global Malaria Programme of WHO for research and training in tropical diseases. World Health Organization, Geneva; 2006
   Google Scholar
• Dondorp A, Nosten F, Stepniewska K, Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 2005;366:717-25
   PubMed Web of Science ®Google Scholar
• Tagbor H, Bruce J, Browne E, Efficacy, safety, and tolerability of amodiaquine plus sulphadoxine-pyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomised trial. Lancet 2006;368:1349-56
   PubMed Web of Science ®Google Scholar
• UNAIDS. WHO. AIDS epidemic update; 2007. UNAIDS/07.27E/JC1322E 2007
   Google Scholar
• Mount AM, Mwapasa V, Elliott SR, Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection. Lancet 2004;363:1860-7
   PubMed Web of Science ®Google Scholar
• Verhoeff FH, Brabin BJ, Hart CA, Increased prevalence of malaria in HIV-infected pregnant women and its implications for malaria control. Trop Med Int Health 1999;4:5-12
   PubMed Web of Science ®Google Scholar
• ter Kuile FO, Parise ME, Verhoeff FH, The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa. Am J Trop Med Hyg 2004;71:41-54
   PubMed Web of Science ®Google Scholar
• Filler SJ, Kazembe P, Thigpen M, Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi. J Infect Dis 2006;194:286-93
   PubMed Web of Science ®Google Scholar
• Steketee RW, Wirima JJ, Bloland PB, Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1. Am J Trop Med Hyg 1996;55:42-9
   PubMed Web of Science ®Google Scholar
• Idemyor V. Human immunodeficiency virus (HIV) and malaria interaction in sub-Saharan Africa: the collision of two Titans. HIV Clin Trials 2007;8:246-53
   PubMed Web of Science ®Google Scholar
• van Eijk AM, Ayisi JG, ter Kuile FO, HIV increases the risk of malaria in women of all gravidities in Kisumu, Kenya. AIDS 2003;17:595-603
   PubMed Web of Science ®Google Scholar
• Skinner-Adams TS, McCarthy JS, Gardiner DL, HIV and malaria co-infection: interactions and consequences of chemotherapy. Trends Parasitol 2008;24:264-71
   PubMed Web of Science ®Google Scholar
• WHO. Guidelines on co-trimoxazole prophylaxis for HIV-related infections among children, adolescents and adults: recommendations for a public health approach; 2006
   Google Scholar